Dialogues

Aug 14, 2025, 02:59

Why Cardio-Oncology Training Matters for Oncologists Treating Patients at Risk | MASCC 2025

In this MASCC 2025 series interview, Stephen Casselli, Executive Director of the International Cardio-Oncology Society, discusses the society’s mission to advance cardio-oncology through education, training, and professional development for all healthcare providers involved in cancer care.

He emphasizes the growing need to address cardiotoxic side effects of cancer treatments—an issue impacting countless patients. Together, they’re working to translate the ESC/IC-OS cardio-oncology guidelines into practical tools for cancer physicians.

This conversation underscores the importance of multidisciplinary partnerships to improve survivorship and long-term outcomes for patients.

This video is part of OncoDaily’s special coverage of the MASCC 2025 Annual Meeting.

cancer cancer care cancer survivorship Cardio-Oncology cardiotoxicity ESC guidelines ICOCS MASCC 2025 multidisciplinary care OncoDaily Oncology oncology leadership Stephen Casselli Supportive CareIn Cancer

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders